POS-258 CARDIOVASCULAR OUTCOMES AND EXPLORATORY ANALYSES BY ACHIEVED HB LEVELS IN THE POOLED PHASE 3 ROXADUSTAT STUDIES OF NON-DIALYSIS-DEPENDENT PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE
Fishbane, S., Provenzano, R., Pergola, P., Szczech, L., Leong, R., Saikali, K., Zhong, M., Lee, T., Little, D., Houser, M., Frison, L., Houghton, J., Yu, K.H.P.
Published in Kidney international reports (01.04.2021)
Published in Kidney international reports (01.04.2021)
Get full text
Journal Article
POS-284 CARDIOVASCULAR OUTCOMES AND EXPLORATORY ANALYSES BY ACHIEVED HB LEVELS IN POOLED PHASE 3 TRIALS OF ROXADUSTAT IN DIALYSIS-DEPENDENT PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE
Provenzano, R., Fishbane, S., Pergola, P., Szczech, L., Leong, R., Saikali, K., Zhong, M., Lee, T., Houser, M., Little, D., Frison, L., Houghton, J., Yu, K.H.P.
Published in Kidney international reports (01.04.2021)
Published in Kidney international reports (01.04.2021)
Get full text
Journal Article
A Double-Blind, Randomized, Placebo-Controlled Trial of Escitalopram in the Treatment of Pediatric Depression
Wagner, Karen Dineen, Jonas, Jeffrey, Findling, Robert L, Ventura, Daniel, Saikali, Khalil
Published in Journal of the American Academy of Child and Adolescent Psychiatry (01.03.2006)
Published in Journal of the American Academy of Child and Adolescent Psychiatry (01.03.2006)
Get more information
Journal Article
Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer
Gomez, Henry L, Philco, Manuel, Pimentel, Patricia, Kiyan, Miriam, Monsalvo, Maria Laura, Conlan, Maureen G, Saikali, Khalil G, Chen, Michael M, Seroogy, Joseph J, Wolff, Andrew A, Escandon, Rafael D
Published in Anti-cancer drugs (01.03.2012)
Published in Anti-cancer drugs (01.03.2012)
Get more information
Journal Article
A Phase I-II Trial of Ispinesib, a Kinesin Spindle Protein Inhibitor, Dosed Every Two Weeks as First Line Chemotherapy for Advanced Locally Recurrent or Metastatic Breast Cancer
Gomez, H., Philco, M., Pimentel, P., Escandon, R., Saikali, K., Seroogy, J., Wolff, A., Conlan, M.
Published in Cancer research (Chicago, Ill.) (15.12.2009)
Published in Cancer research (Chicago, Ill.) (15.12.2009)
Get full text
Journal Article
A phase I/II trial of ispinesib, a kinesin spindle protein (KSP) inhibitor, dosed q14d in patients with advanced breast cancer previously untreated with chemotherapy for metastatic disease or recurrence
Gomez, H. L., Philco, M., Castaneda, C., Pimentel, P., Escandon, R., Seroogy, J., Saikali, K., Wolff, A., Conlan, M.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
A phase I-II open-label trial of ispinesib on an alternate dosing schedule in chemotherapy-naive patients with locally advanced or metastatic breast cancer (MBC)
Philco, M., Falcon, S., Gomez, H., Escandon, R., Saikali, K., Wolff, A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A phase I-II trial of Ispinesib , a kinesin spindle protein inhibitor, dosed every two weeks in patients with locally advanced or metastatic breast cancer previously untreated with chemotherapy for metastatic disease or recurrence
Gomez, H, Castaneda, C, Philco, M, Pimentel, P, Falcon, S, Escandon, R, Saikali, K, Conlan, M, Seroogy, J, Wolff, A
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Get full text
Journal Article
A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 Dosed Q14D without and with Prophylactic G-CSF in Non-Hodgkin (NHL) or Hodgkin Lymphoma (HL)
O'Connor, Owen A, Gerecitano, J., Van Deventer, H., Afanasyev, B., Hainsworth, J., Chen, M., Saikali, K., Seroogy, J., Escandon, R., Wolff, A., Conlan, MG
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma
Gerecitano, John, O'Connor, O., Van Deventer, H., Hainsworth, J., Leonard, J., Goy, A., Afanasyev, B., Chen, M., Saikali, K., Conlan, M. G, Escandon, R, Wolff, A
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Automation of disassembly processes and its information systems
David, B.T., Boutros, N., Saikali, K., Chevron, D., Gerner, S., Skaf, A., Binder, Z., Dubois, M.
Published in Proceedings First International Symposium on Environmentally Conscious Design and Inverse Manufacturing (1999)
Published in Proceedings First International Symposium on Environmentally Conscious Design and Inverse Manufacturing (1999)
Get full text
Conference Proceeding
First clinical trial of the selective cardiac myosin activator, CK-1827452, in Heart Failure: effect of dose and plasma concentration on systolic function
CLELAND, J, MCMURRAY, J, LANG, C, CLARKE, C, NEYSES, L, SAIKALI, K, LEE, J, GOLDMAN, J, TEERLINK, J, MALIK, F
Published in European journal of heart failure. Supplements (01.06.2008)
Published in European journal of heart failure. Supplements (01.06.2008)
Get full text
Journal Article
More powerful tests for the sign testing problem
Saikali, Khalil G., Berger, Roger L.
Published in Journal of statistical planning and inference (01.09.2002)
Published in Journal of statistical planning and inference (01.09.2002)
Get full text
Journal Article